Laura Oliphant - 31 Jul 2023 Form 4 Insider Report for AEHR TEST SYSTEMS (AEHR)

Role
Director
Signature
/s/ Chris Siu, Attorney-in-fact
Issuer symbol
AEHR
Transactions as of
31 Jul 2023
Net transactions value
-$553,670
Form type
4
Filing time
02 Aug 2023, 16:01:44 UTC
Previous filing
12 Jul 2023
Next filing
27 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AEHR Common Stock Options Exercise $12,600 +7,500 $1.68* 7,500 31 Jul 2023 Direct
transaction AEHR Common Stock Options Exercise $3,350 +2,500 +33% $1.34* 10,000 31 Jul 2023 Direct
transaction AEHR Common Stock Sale $516,700 -10,000 -100% $51.67 0 31 Jul 2023 Direct F1
transaction AEHR Common Stock Sale $52,920 -1,008 -7.4% $52.50 12,665 01 Aug 2023 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEHR Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,500 -100% $0.000000* 0 31 Jul 2023 Common Stock 2,500 $1.34 Direct F3
transaction AEHR Non-Qualified Stock Option (right to buy) Options Exercise $0 -7,500 -100% $0.000000* 0 31 Jul 2023 Common Stock 7,500 $1.68 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.65 to $51.81, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
F2 The amount reported includes shares subject to unvested restricted stock units.
F3 One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.
F4 One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Remarks:

Ex. 24 - Power of Attorney